With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global X-Linked Hypophosphatemia Market as well as the factors ...

The monoclonal antibody burosumab improved multiple biochemical measures and patient-reported outcomes among children and ...

Expanded dosing options support individualized treatment for adults with XLHPRINCETON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, ...

Treatment goals include optimizing growth and functionality, increasing phosphate levels in the body, and managing pain. Treatments are ongoing, and include newer targeted therapies available for ...

The pharmaceutical drug Injectafer (generic name: ferric carboxymaltose), an iron carbohydrate complex used to treat iron deficiency anemia, has been linked to severe hypophosphatemia (HPP) – a ...

X-linked hypophosphatemia (XLH) is a genetic disorder affecting the bones, which presents with a wide spectrum of clinical severity, ranging from simple low blood phosphate levels to severe bowlegs.

Researchers have found in a new research that patients with X-linked hypophosphatemia (XLH) are prone to spontaneous dental ...

The FDA has expanded the approval of Crysvita (burosumab; Ultragenyx and Kyowa Kirin) to include treatment in pediatric patients as young as 6 months with X-linked hypophosphatemia. The Food and Drug ...

To foster robust business growth in today’s rapidly evolving marketplace, companies should wholeheartedly embrace the indispensable role of market research reports. The X Linked Hypophosphatemia (XLH) ...

Please provide your email address to receive an email when new articles are posted on . Sustained burosumab therapy for more than 3 years for children with X-linked hypophosphatemia resulted in ...

In X-linked hypophosphatemia, phosphate wasting results from increased circulating levels of fibroblast growth factor 23 (FGF-23). 1 Administration of calcitonin to a patient with oncogenic ...

X-linked hypophosphatemia (XLH) is the classical bone disorder caused by renal wasting of the phosphate. Formerly called vitamin D-resistant rickets, it is the most frequently observed condition among ...